WallStreetZenWallStreetZen

NYSE: MCK
Mckesson Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for MCK

Based on 12 analysts offering 12 month price targets for Mckesson Corp

Min Forecast
$770.00-7.2%
Avg Forecast
$876.25+5.61%
Max Forecast
$980.00+18.11%

Should I buy or sell MCK stock?

Based on 12 analysts offering ratings for Mckesson Corp.

Strong Buy
Strong Buy
7 analysts 58.33%
Buy
3 analysts 25%
Hold
2 analysts 16.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model "Buy" agrees with analyst consensus with a "Strong Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their MCK stock forecasts and price targets.

MCK stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-11-10
lockedlocked$00.00+00.00%2025-11-06
lockedlocked$00.00+00.00%2025-11-06
lockedlocked$00.00+00.00%2025-11-06Find Out Why
lockedlocked$00.00+00.00%2025-10-14Find Out Why
JP Morgan
Top 19%
82
Strong BuyMaintains$853.00+2.81%2025-09-26
Evercore ISI Group
Bottom 11%
11
BuyMaintains$825.00-0.57%2025-09-24
TD Cowen
Bottom 4%
4
Strong BuyMaintains$864.00+4.13%2025-09-24
Citigroup
Bottom 4%
4
Strong BuyMaintains$860.00+3.65%2025-09-24
Mizuho
Bottom 7%
7
HoldMaintains$770.00-7.20%2025-09-24

1 of 2

Forecast return on equity

Is MCK forecast to generate an efficient return?

Company
-356.54%
Industry
-97.8%
Market
230.63%
MCK's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MCK forecast to generate an efficient return on assets?

Company
7.37%
Industry
6.36%
MCK is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MCK earnings per share forecast

What is MCK's earnings per share in the next 3 years based on estimates from 19 analysts?

Avg 1 year Forecast
$39.07+21.39%
Avg 2 year Forecast
$44.26+37.48%
Avg 3 year Forecast
$50.23+56.05%
MCK's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

MCK revenue forecast

What is MCK's revenue in the next 3 years based on estimates from 19 analysts?

Avg 1 year Forecast
$412.4B+6.55%
Avg 2 year Forecast
$446.7B+15.41%
Avg 3 year Forecast
$483.2B+24.83%
MCK's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MCK earnings growth forecast

How is MCK forecast to perform vs Medical Distribution companies and vs the US market?

Company
15.88%
Industry
24.76%
Market
43.09%
MCK's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
MCK's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
MCK's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

MCK revenue growth forecast

How is MCK forecast to perform vs Medical Distribution companies and vs the US market?

Company
7.64%
Industry
7.42%
Market
25.71%
MCK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MCK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MCK vs Medical Distribution Stocks

TickerPricePrice TargetUp/downsideConsensus
MCK$829.70$876.25+5.61%Strong Buy
COR$350.67$380.25+8.44%Strong Buy
CAH$205.13$207.22+1.02%Strong Buy
HSIC$71.67$74.40+3.81%Hold
AHG$1.44N/AN/A
View Top Medical Distribution Stocks

Mckesson Stock Forecast FAQ

Is Mckesson Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 12 Wall Street analysts covering (NYSE: MCK) stock is to Strong Buy MCK stock.

Out of 12 analysts, 7 (58.33%) are recommending MCK as a Strong Buy, 3 (25%) are recommending MCK as a Buy, 2 (16.67%) are recommending MCK as a Hold, 0 (0%) are recommending MCK as a Sell, and 0 (0%) are recommending MCK as a Strong Sell.

If you're new to stock investing, here's how to buy Mckesson stock.

What is MCK's earnings growth forecast for 2026-2028?

(NYSE: MCK) Mckesson's forecast annual earnings growth rate of 15.88% is not forecast to beat the US Medical Distribution industry's average forecast earnings growth rate of 24.76%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 43.09%.

Mckesson's earnings in 2025 is $4,033,000,000.On average, 19 Wall Street analysts forecast MCK's earnings for 2026 to be $4,822,797,607, with the lowest MCK earnings forecast at $4,654,468,342, and the highest MCK earnings forecast at $5,032,289,660. On average, 17 Wall Street analysts forecast MCK's earnings for 2027 to be $5,462,382,165, with the lowest MCK earnings forecast at $5,174,588,245, and the highest MCK earnings forecast at $5,732,118,766.

In 2028, MCK is forecast to generate $6,200,201,993 in earnings, with the lowest earnings forecast at $5,778,169,249 and the highest earnings forecast at $6,612,089,067.

What is MCK's revenue growth forecast for 2026-2028?

(NYSE: MCK) Mckesson's forecast annual revenue growth rate of 7.64% is forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 7.42%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.71%.

Mckesson's revenue in 2025 is $387,094,000,000.On average, 19 Wall Street analysts forecast MCK's revenue for 2026 to be $50,905,964,099,350, with the lowest MCK revenue forecast at $48,930,150,286,150, and the highest MCK revenue forecast at $53,434,359,024,600. On average, 17 Wall Street analysts forecast MCK's revenue for 2027 to be $55,139,868,474,300, with the lowest MCK revenue forecast at $51,674,912,128,850, and the highest MCK revenue forecast at $58,739,483,294,900.

In 2028, MCK is forecast to generate $59,642,719,519,600 in revenue, with the lowest revenue forecast at $54,722,809,823,950 and the highest revenue forecast at $64,908,347,261,900.

What is MCK's forecast return on assets (ROA) for 2026-2028?

(NYSE: MCK) forecast ROA is 7.37%, which is higher than the forecast US Medical Distribution industry average of 6.36%.

What is MCK's Price Target?

According to 12 Wall Street analysts that have issued a 1 year MCK price target, the average MCK price target is $876.25, with the highest MCK stock price forecast at $980.00 and the lowest MCK stock price forecast at $770.00.

On average, Wall Street analysts predict that Mckesson's share price could reach $876.25 by Nov 10, 2026. The average Mckesson stock price prediction forecasts a potential upside of 5.61% from the current MCK share price of $829.70.

What is MCK's Earnings Per Share (EPS) forecast for 2026-2028?

(NYSE: MCK) Mckesson's current Earnings Per Share (EPS) is $32.19. On average, analysts forecast that MCK's EPS will be $39.07 for 2026, with the lowest EPS forecast at $37.71, and the highest EPS forecast at $40.77. On average, analysts forecast that MCK's EPS will be $44.26 for 2027, with the lowest EPS forecast at $41.92, and the highest EPS forecast at $46.44. In 2028, MCK's EPS is forecast to hit $50.23 (min: $46.81, max: $53.57).

What is MCK's forecast return on equity (ROE) for 2026-2028?

(NYSE: MCK) forecast ROE is -356.54%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.